Another study revealed that pioglitazone, a peroxisome proliferator-activated receptor-γ (PPARγ) agonist and an antihyperglycemic drug against type 2 diabetes as well as an antineoplastic drug, inhibit proliferation and induce apoptosis of glioma cells by down-regulating REST mRNA [105]. This evidence concerns the gene REST and central nervous system cancer.